Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 2/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.40 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.40 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.40 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.40 |
| ▸ | HTT | P42858 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.36 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.36 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.36 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.36 |
| ▸ | KCNN4 | O15554 | 1/20 | 0.36 |
| ▸ | NPC1 | O15118 | 1/20 | 0.35 |
| ▸ | POLB | P06746 | 1/20 | 0.35 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.35 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.35 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.35 |
| ▸ | MAPT | P10636 | 1/20 | 0.35 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26002503 | 0.89 | MEN1 (0.38) | MEN1KMT2ACYP3A4CYP2C9CYP2C19 | |
| SCHEMBL24433604 | 0.85 | ALDH1A1 (0.43) | CYP3A4SMN1; SMN2ALDH1A1MAPK1CYP1A2 | |
| SCHEMBL20333509 | 0.85 | MEN1 (0.35) | MEN1KMT2ACYP3A4CYP2C9CYP2C19 | |
| SCHEMBL26002570 | 0.83 | MEN1 (0.38) | MEN1KMT2ACYP3A4CYP2C9CYP2C19 | |
| Carbazole SCHEMBL29263416 | 0.81 | ALDH1A1 (0.54) | MEN1KMT2ASMN1; SMN2HTTALDH1A1 | |
| SCHEMBL29027385 | 0.79 | MEN1 (0.36) | MEN1KMT2ACYP3A4CYP2C9CYP2C19 | |
| SCHEMBL24433605 | 0.79 | MAOA (0.40) | MEN1KMT2ACYP3A4CYP2C9CYP2C19 | |
| SCHEMBL29882223 | 0.78 | MEN1 (0.38) | MEN1KMT2ACYP3A4CYP2C9CYP2C19 | |
| SCHEMBL635129 | 0.78 | MEN1 (0.42) | MEN1KMT2ACYP3A4CYP2C9CYP2C19 | |
| SCHEMBL45354 | 0.77 | MEN1 (0.40) | MEN1KMT2ACYP3A4CYP2C9CYP2C19 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 230 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114957240-B | Preparation method and application of carbonyl ring-closed arylamine fluorescent compound | 广东工业大学 | 2024-07-19 | — | — | CN | claimed |
| CN-118027031-A | Carbonyl ring-closed arylamine fluorescent compound with narrow band emission, and preparation method and application thereof | 广东工业大学 | 2024-05-14 | — | — | CN | claimed |
| CN-117835718-A | White light organic electroluminescent composition and application thereof | 深圳大学 | 2024-04-05 | — | — | CN | claimed |
| CN-117003753-A | Carbonyl arylamine pi stacking fluorescent dye and preparation method thereof | 广东工业大学 | 2023-11-07 | — | — | CN | claimed |
| CN-116283984-A | Organic thermal delay fluorescent material based on di-tert-butylaniline donor and preparation method thereof | 电子科技大学 | 2023-06-23 | — | — | CN | claimed |
| CN-114957240-A | Preparation method and application of carbonyl closed-loop arylamine fluorescent compound | 广东工业大学 | 2022-08-30 | — | — | CN | claimed |
| CN-110627832-A | Preparation method for synthesizing tenofovir alafenamide by oxidation method | 江西农业大学 | 2019-12-31 | — | — | CN | claimed |
| CN-110590844-A | Preparation method for synthesizing tenofovir alafenamide by two-step method | 江西农业大学 | 2019-12-20 | — | — | CN | claimed |
| CN-110551153-A | Preparation method for synthesizing tenofovir alafenamide by three-step method | UNIV JIANGXI AGRICULTURAL | 2019-12-10 | — | — | CN | claimed |
| EP-1633364-B1 | PROCESSES FOR THE PRODUCTION OF SILDENAFIL BASE AND CITRATE SALT | TEVA PHARMA (IL) | 2008-02-27 | — | — | EP | claimed |
| JP-2007517803-A | — | — | 2007-07-05 | — | — | JP | claimed |
| EP-1779852-A2 | Methods for the production of sildenafil base and citrate salt | TEVA PHARMACEUTICAL INDUSTRIES LTD. (IL) | 2007-05-02 | — | — | EP | claimed |
| EP-1633364-A2 | METHODS FOR THE PRODUCTION OF SILDENAFIL BASE AND CITRATE SALT | TEVA PHARMACEUTICAL INDUSTRIES LTD. (IL) | 2006-03-15 | — | — | EP | claimed |
| US-20050182066-A1 | Methods for the production of sildenafil base and citrate salt | TEVA PHARMACEUTICALS USA, INC. | 2005-08-18 | — | — | US | claimed |
| WO-2005067936-A2 | METHODS FOR THE PRODUCTION OF SILDENAFIL BASE AND CITRATE SALT | TEVA PHARMACEUTICAL INDUSTRIES LTD. (IL) | 2005-07-28 | — | — | WO | claimed |
| CN-114685539-B | Organic compound, application thereof and organic electroluminescent device using same | Beijing Dingcai Technology Co.,Ltd. (CN) | 2026-05-26 | — | — | CN | disclosed |
| EP-4731689-A1 | METHOD FOR THE PRODUCTION OF THERMOPLASTIC POLYOXAZOLIDINONE | Covestro Deutschland AG (DE) | 2026-04-29 | — | — | EP | disclosed |
| US-4636574-A | Process for preparing arylisothiocyanates | ETHYL CORPORATION (US) | 1987-01-13 | — | — | US | disclosed |
| EP-0177916-A1 | Mono-tertiary-alkylated toluenediamine and derivatives | AIR PRODUCTS AND CHEMICALS, INC. (US) | 1986-04-16 | — | — | EP | disclosed |
| US-4157343-A | Preparation of aromatic diamines | UOP INC. (US) | 1979-06-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050182066-A1 | Methods for the production of sildenafil base and citrate salt | PDE3A, PDE5A, PDE9A | MEN1 2391/4885KMT2A 1927/4885CYP3A4 377/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.